ONCAlert | 2017 San Antonio Breast Cancer Symposium

JAVELIN Trial Design and Safety Results in Gastric Cancer

Hendrik-Tobias Arkenau, MD, PhD
Published Online:4:19 PM, Tue July 19, 2016


Hendrik-Tobias Arkenau, MD, PhD, founding medical director, executive medical director, Sarah Cannon Research Institute UK, gives an overview of the JAVELIN trial in gastric cancer. He also discusses the safety profile of avelumab.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.